Microbial Contamination Prompts Recall of Homeopathic Allergy Medicine By Brian Park, PharmD Publish Date June 15, 2022
Homeopathic Med Used for Snoring Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date June 13, 2022
Antacid, Constipation Products Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date June 10, 2022
FDA Withdraws Approval of Ukoniq Over Safety Concerns By Brian Park, PharmD Publish Date June 2, 2022
Dissolution Test Failure Prompts Recall of Anagrelide Capsules By Steve Duffy Publish Date May 26, 2022
FDA Issues Safety Alert for COVID-19 Test Over Concerns of False Results By Brian Park, PharmD Publish Date May 12, 2022
FDA Warns of Potential Chemical Exposure With Certain Hemodialysis Machines By Brian Park, PharmD Publish Date May 9, 2022
Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments By Brian Park, PharmD Publish Date May 4, 2022
Microbial Contamination Prompts Recall of Suspending Agent Used in Compounding By Steve Duffy Publish Date May 3, 2022
FDA: Airway Obstruction Possible With Silicone-Based EMG Endotracheal Tubes By Diana Ernst, RPh Publish Date May 2, 2022
Investigation Into Counterfeit HIV Med Spurs Legal Action By Diana Ernst, RPh Publish Date April 27, 2022
Accupril Tablets Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date April 25, 2022
Hidden Drugs Found in Supplements Promoted for Musculoskeletal Conditions By Diana Ernst, RPh Publish Date April 21, 2022
Risk of False Results Possible With Noninvasive Prenatal Screening Tests By Diana Ernst, RPh Publish Date April 20, 2022
Warning Letters Sent to Companies Illegally Selling OTC Skin Lightening Products By Brian Park, PharmD Publish Date April 19, 2022
Ukoniq Taken Off the Market; Pending Applications for CLL, SLL Withdrawn By Brian Park, PharmD Publish Date April 15, 2022
Missing Label on Vial Prompts Recall of Long-Acting Insulin Analog By Brian Park, PharmD Publish Date April 13, 2022
Warning Letters Sent to Online Pharmacies Illegally Selling Schedule II Stimulants By Brian Park, PharmD Publish Date April 12, 2022
Idarubicin Hydrochloride Injection Recalled Due to Presence of Particulate in Vial By Brian Park, PharmD Publish Date April 1, 2022
FDA: Monitor Young Children for Thyroid Dysfunction After Exposure to Iodinated Contrast Media By Brian Park, PharmD Publish Date March 31, 2022
Nitrosamine Impurity Detected in Certain Lots of Orphenadrine Citrate ER Tablets By Brian Park, PharmD Publish Date March 24, 2022
Accuretic, Authorized Generics Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date March 23, 2022
Reports of Injuries Prompt FDA Alert on Proper At-Home COVID-19 Test Use By Brian Park, PharmD Publish Date March 23, 2022
Syringe Malfunction Prompts Recall of Anaphylaxis Treatment By Brian Park, PharmD Publish Date March 22, 2022
FDA Recommendations for Current Shortage of Prefilled Saline Flush Syringes By Brian Park, PharmD Publish Date March 21, 2022
FDA: Do Not Use Renuvion/J-Plasma Device for Skin Improvement Procedures By Diana Ernst, RPh Publish Date March 16, 2022
FDA Tells Philips Respironics to Increase Awareness of Product Recall By Diana Ernst, RPh Publish Date March 11, 2022
Certain Immune Globulin Products Withdrawn Due to Higher Rate of Hypersensitivity Reactions By Brian Park, PharmD Publish Date March 9, 2022
Sodium Acetate Injection Recalled Due to Particulate Matter in Vials By Brian Park, PharmD Publish Date March 7, 2022
FDA: These Unauthorized COVID-19 Tests Should Not Be Used By Brian Park, PharmD Publish Date March 2, 2022
FDA: Safety Concerns With Compounded Ketamine Nasal Spray By Brian Park, PharmD Publish Date February 17, 2022
FDA Warns of Possible Strangulation With Enteral Feeding Set Tubing By Diana Ernst, RPh Publish Date February 9, 2022
FDA: Empowered Diagnostics COVID-19 Tests Should Not Be Used By Brian Park, PharmD Publish Date February 2, 2022
Polymyxin B for Injection Recalled Due to Hair Found in Vial By Brian Park, PharmD Publish Date January 31, 2022
Wound Care Gel Recalled Due to Bacterial Contamination By Brian Park, PharmD Publish Date January 27, 2022
Insulin Prefilled Pens Recalled Due to Missing Label By Brian Park, PharmD Publish Date January 20, 2022
Counterfeit HIV Medications Removed From US Supply Chain By Brian Park, PharmD Publish Date January 20, 2022
FDA Warns Against Using LuSys Laboratories COVID-19 Tests By Brian Park, PharmD Publish Date January 14, 2022
FDA: Transmucosal Buprenorphine Medications Linked to Dental Issues By Brian Park, PharmD Publish Date January 13, 2022
Device Malfunction Reports Prompt Recall of Embolic Protection System By Brian Park, PharmD Publish Date January 11, 2022
Corticosteroid Ointment Recalled Due to Bacterial Contamination By Brian Park, PharmD Publish Date January 5, 2022
Possible Defective Delivery System Prompts Recall of Nitroglycerin Lingual Spray By Brian Park, PharmD Publish Date December 28, 2021
High Temperature Exposure Prompts Recall of Anticoagulant Med By Brian Park, PharmD Publish Date December 7, 2021
Two Lots of COVID-19 Antiviral Drug Veklury Recalled By Brian Park, PharmD Publish Date December 6, 2021
Sterility Issue Prompts Recall of Injectable Antiepileptic Drug By Brian Park, PharmD Publish Date November 22, 2021
FDA Adds Restrictions, Updates Labeling for Breast Implants By Brian Park, PharmD Publish Date October 28, 2021
Pepaxto Withdrawn from US Market Following OCEAN Trial Results By Brian Park, PharmD Publish Date October 22, 2021
Cubicin Recall Initiated Due to Glass Particles Found in Vial By Brian Park, PharmD Publish Date October 21, 2021
Antihypertensive Meds Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date October 14, 2021
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers By Diana Ernst, RPh Publish Date October 12, 2021
Lotrimin, Tinactin Spray Products Recalled Due to Presence of Benzene By Brian Park, PharmD Publish Date October 4, 2021
FDA: Risk of LAAO Implant-Related Adverse Events May Be Higher for Women By Diana Ernst, RPh Publish Date September 28, 2021
Glucagon Emergency Kit Recalled Due to Loss of Potency By Brian Park, PharmD Publish Date September 27, 2021
Pfizer Expands Recall to All Lots of Chantix Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date September 17, 2021
Ruzurgi Tablets Recalled Due to Yeast, Mold, Bacterial Contamination By Brian Park, PharmD Publish Date September 14, 2021
Warning Letters Sent to Companies Selling Supplements Claiming to Treat Diabetes By Brian Park, PharmD Publish Date September 10, 2021
Lidocaine HCI Topical Solution Recalled Due to Super Potency By Brian Park, PharmD Publish Date September 8, 2021
Recall of Amino Acid Injection Initiated Due to Visible Particulate Matter By Diana Ernst, RPh Publish Date September 7, 2021
FDA: New Warnings and Limitations Set for Certain JAK Inhibitors By Brian Park, PharmD Publish Date September 1, 2021
Pfizer Expands Chantix Recall Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date August 19, 2021
Sodium Bicarbonate Injection Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date August 11, 2021
Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue By Diana Ernst, RPh Publish Date August 9, 2021
Oteseconazole Gets Priority Review for Recurrent Vulvovaginal Candidiasis By Brian Park, PharmD Publish Date July 28, 2021
FDA: Increased Risk of Death Reported in Pepaxto Confirmatory Trial By Brian Park, PharmD Publish Date July 28, 2021
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy By Diana Ernst, RPh Publish Date July 19, 2021
Presence of Benzene Prompts Recall of Neutrogena, Aveeno Sunscreens By Brian Park, PharmD Publish Date July 15, 2021
Neulasta Ad Claims Misleading, May Undermine Biosimilar Use, Says FDA By Diana Ernst, RPh Publish Date July 15, 2021
